Status:
COMPLETED
Improving Communication During a Pandemic Flu Outbreak
Lead Sponsor:
King's College London
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Public Health England
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
During the last pandemic influenza antivirals were prescribed both as prophylaxis and treatment. However, adherence rates were suboptimal. This study assessed the effect of theory-based and evidence-b...
Detailed Description
Background: In 2009, a new strain of influenza virus, called pandemic influenza A(H1N1)pdm09, was detected in humans. During the pandemic in 2009/2010, antiviral medications were prescribed both as pr...
Eligibility Criteria
Inclusion
- To be eligible to participate, respondents had to be members of the UK general public in the adult age range (18-65 years), and be fluent in English.
Exclusion
- non-UK residents
- younger than 18 or older than 65
- not fluent in English
Key Trial Info
Start Date :
May 26 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 8 2016
Estimated Enrollment :
349 Patients enrolled
Trial Details
Trial ID
NCT03431012
Start Date
May 26 2016
End Date
June 8 2016
Last Update
December 16 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.